A. Sierra et al., ASTROCYTE-DERIVED CYTOKINES CONTRIBUTE TO THE METASTATIC BRAIN SPECIFICITY OF BREAST-CANCER CELLS, Laboratory investigation, 77(4), 1997, pp. 357-368
The occurrence of breast cancer metastases is preferential to certain
organs. Astrocytes may play an important role in the development of br
ain metastases, as these cells have been shown to respond to extracell
ular stimuli by producing many cytokines and growth factors that can m
odulate tumor cell proliferation, growth, and/or metastases. To test t
his hypothesis, we analyzed the responses of the human breast cancer c
ell line MDA-MB-435 and its metastatic sublines to astrocyte primary c
ultures from newborn rat cerebra. Astrocyte purity of the glial cell c
ultures was demonstrated by glial fibrillary acidic protein and rat ne
ural antigen-2 (Ran-2) immunopositive staining. The 435-Br1 cell line,
which was derived from a brain metastases in a nude mouse, showed inc
reased adhesion to astrocytes and enhanced growth in vitro in the pres
ence of media from Con A-stimulated astrocytes, relative to the parent
al MDA-MB-435 and the lung metastasis-derived variant 435-Lung2. Furth
ermore, the growth-stimulatory effect was partially reversed by anti-I
L-6, anti-transforming growth factor beta (anti-TGF beta), and anti-IG
F-I antibodies, indicating that these metastatic cells use exogenous c
ytokines as paracrine growth factors. In an attempt to elucidate the r
ole of several biologic-response modifiers produced by astrocytes, we
tested the responses of MDA-MB-435 cells to purified cytokines and gro
wth factors. We found that the addition of recombinant human or mouse
IL-6 produced a variety of responses in the different 435 metastatic v
ariants. Furthermore, IL-6 receptor (IL-6R) expression was slightly in
creased in the 435-Br1 cells, and exogenous IL-6 rescued 435-Br1 cells
from apoptosis in serum-depleted cultures. No apoptotic protective ef
fect was observed in either MDA-MB-435 parental cells or 435-Lung2 cel
ls. Thus, responses to exogenous IL-6 might determine the differences
among these metastatic variants by extending cell survival of selected
subpopulations, giving them the opportunity to respond to growth fact
ors or other favorable conditions that might be present. These results
suggest that cytokines produced by glial cells in vivo may contribute
, in a paracrine manner, to the development of brain metastases by bre
ast cancer cells.